Differentiated Thyroid Cancer (DTC)

Also known as: Differentiated Thyroid Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00024Thyrotropin alfa1Recruiting1
DB11595Atezolizumab1 / 2Recruiting1
DB05153Cabozantinib1 / 2Recruiting1
DB08875Cabozantinib1 / 2Recruiting1
DB00773Etoposide1 / 2Active Not Recruiting1
DB01181Ifosfamide1 / 2Active Not Recruiting1
DB09078Lenvatinib1 / 2Active Not Recruiting1
DB15414CM-43072Completed1
DB11891CUDC-9072Terminated1
DB08875Cabozantinib2Active Not Recruiting1
DB08875Cabozantinib2Recruiting1
DB05351Dexlansoprazole2Recruiting1
DB11074Dimethicone2Recruiting1
DB01590Everolimus2Active Not Recruiting1
DB09078Lenvatinib2Recruiting1
DB00264Metoprolol2Recruiting1
DB09079Nintedanib2Active Not Recruiting1
DB09496Octinoxate2Recruiting1
DB01428Oxybenzone2Recruiting1
DB00398Sorafenib2Active Not Recruiting1
DB00398Sorafenib2Recruiting1
DB01268Sunitinib2Completed1
DB05294Vandetanib2Recruiting1
DB11885Anlotinib2 / 3Active Not Recruiting1
DB15414CM-43073Recruiting1
DB08875Cabozantinib3Recruiting1
DB09078Lenvatinib3Active Not Recruiting1
DB14765Rivoceranib3Recruiting1
DB11689Selumetinib3Completed1
DB00024Thyrotropin alfa3Completed1
DB05294Vandetanib3Active Not Recruiting1
DB00630Alendronic acidNot AvailableRecruiting1
DB06724Calcium CarbonateNot AvailableRecruiting1
DB09078LenvatinibNot AvailableApproved for Marketing1